Nanomedicines and Vaccines
NANO-VAC
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (8)
2022
-
A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199
-
Consensus on the Definition of Control and Remission in Chronic Urticaria
Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269
-
Daily Clinical Practice in the Management of Chronic Urticaria in Spain: Results of the UCREX Study
Actas Dermo-Sifiliograficas, Vol. 113, Núm. 1, pp. T4-T14
2019
-
Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)
Health and Quality of Life Outcomes, Vol. 17, Núm. 1
-
Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez
Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348
2017
-
Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements
Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144
2015
-
Management of urticaria: Not too complicated, not too simple
Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743
2013
-
Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice
Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228